Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Ra Capital Management, L.P. reported a 9.90% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Karyopharm Therapeutics Inc., 2,302,504 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 2,302,504
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 2,302,504 |
| Peter Kolchinsky | 9.90% | 2,302,504 |
| Rajeev Shah | 9.90% | 2,302,504 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 2,302,504 |
Source
Related
- Karyopharm Therapeutics Inc.
- Ra Capital Management, L.P.
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Apr 2, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026